Jennifer Cygan

Jennifer Cygan is an accomplished business leader in the biotech industry with extensive experience in strategic business development and management. Currently serving as Chief Business Officer at EpiBiologics and as a Board Member at Casma Therapeutics, Jennifer also provides consulting services to early-stage companies. Previous roles include Co-Founder and Chief Business Officer at Broadwing Bio, Chief Business Officer at GenEdit and Eikon Therapeutics, and Vice President at Calico Life Sciences, where Jennifer built project teams and managed high-profile alliances. Additional experience includes key positions at Genentech and Genencor, as well as a senior licensing role at the University of California, San Francisco. Jennifer holds a Ph.D. in Biology from Harvard University and a B.S. in Microbiology from the University of Illinois Urbana-Champaign.